Key result
Severe hypertension-induced renal TMA links to favorable renal recovery, with persistent dialysis in only ~19%.
Observational (n=21)
Answers are grounded in this paper and cite their sources.
Renal thrombotic microangiopathy (TMA) is an uncommon vascular complication of severe hypertension. Until now, its clinical-pathological characteristics and renal survival have been unclear. Twenty-one patients with biopsy-proven renal TMA and with severe or malignant hypertension were retrospectively studied. All the patients exhibited severe hypertension, with systolic blood pressure at 200-280 mmHg and diastolic pressure at 110-180 mmHg. No patients had hemorrhagic manifestations. Elevated lactate dehydrogenase and thrombocytopenia were found in 6 and 5 patients, respectively. Significant proteinuria (>3 g/day) was present in 2 patients and microscopic hematuria in 18 patients. All patients presented with renal insufficiency (creatinine 3.1+/-2.1 mg/dL). The level of von Willebrand factor:antigen (vWF:Ag) in patients was not significantly higher than that in the healthy subjects, while the ADAMTS13 (a disintegrin and metalloprotease, with thrombospondin-1-like domains) activity was not significantly lower than that in the healthy subjects. Renal histology showed a TMA involving preglomerular arterioles and/or interlobular arteries characterized by fibrin deposits and vascular wall sclerosis. Fibrin glomerular microthrombi were not observed in these patients. Four patients required hemodialysis upon admission for severe acute renal failure. On follow-up, 3 patients had recovered normal renal function and 14 had mild renal insufficiency (creatinine 1.8+/-0.3 mg/dL), while 4 patients still required persistent hemodialysis. In conclusion, compared with patients having hemolytic uremic syndrome/thrombocytopenic purpura, our patients showed a low incidence of thrombocytopenia and better renal outcome.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2008) conducted an observational in Biopsy-proven renal thrombotic microangiopathy with severe or malignant hypertension (n=21). Severe or malignant hypertension vs. Healthy subjects was evaluated on Renal survival / persistent hemodialysis requirement on follow-up. Severe hypertension-induced renal TMA resulted in low thrombocytopenia rates (5/21) and favorable renal outcomes, with 3/21 recovering normal function and 14/21 having mild renal insufficiency.
Synapse has enriched 10 related papers. Consider them for comparative context: